Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban

Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist oral anticoagulants (NOACs). The objective of this retrospective claims observational cohort study was to compare the risk of bleeding among non-valvular atrial fibrillation (NVAF) patients prescribed...

Descripción completa

Detalles Bibliográficos
Autores principales: Tepper, Ping G., Mardekian, Jack, Masseria, Cristina, Phatak, Hemant, Kamble, Shital, Abdulsattar, Younos, Petkun, William, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211674/
https://www.ncbi.nlm.nih.gov/pubmed/30383768
http://dx.doi.org/10.1371/journal.pone.0205989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211674/
https://www.ncbi.nlm.nih.gov/pubmed/30383768
http://dx.doi.org/10.1371/journal.pone.0205989

Ejemplares similares